Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01013818 · ClinicalTrials.gov registry record · Phase 1
A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1 study, sponsored by Human Genome Sciences.
- Terminated
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT01013818: Clinical Trial Phase 1 study, sponsored by Human Genome Sciences.
NCT01013818 is a Phase 1 study that was terminated before completion, run by Human Genome Sciences. The registered enrollment target is 11 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01013818, a Phase 1 study, was terminated before completion, sponsored by Human Genome Sciences.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if HGS1029 is safe and well tolerated in patients with relapsed or refractory lymphoid malignancies.
Interventions
- DRUG HGS1029
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-10 |
| Phase | Phase 1 |
Why NCT01013818 stopped before completion
NCT01013818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which HGS1029 is the first listed.
NCT01013818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01013818 about?
NCT01013818 is a clinical study titled "A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies". The purpose of this study is to determine if HGS1029 is safe and well tolerated in patients with relapsed or refractory lymphoid malignancies.
What is the current status of trial NCT01013818?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2009-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01013818?
The interventions under investigation include: HGS1029 (DRUG).
Who is sponsoring clinical trial NCT01013818?
This trial is sponsored by Human Genome Sciences, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01013818's enrollment target sits among peer trials
11 1911th of 2000 higher than 88 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia